Cultivated Wheat Pollen Allergy Shots: Five Conditions, One Plant, One Clear Distinction
Cultivated wheat pollen allergy shots (SCIT) address an aeroallergen condition distinct from five commonly confused wheat-related conditions: wheat food allergy, celiac disease, wheat-dependent exercise-induced anaphylaxis (WDEIA/Tri a 19), baker's asthma, and non-celiac gluten sensitivity. Triticum aestivum pollen falls within Pooideae and cross-reacts strongly with Timothy (Tri a 1/5 versus Phl p 1/5), so a standard Pooideae grass mix vial typically provides empirical coverage for Plains and Pacific Northwest grain farmers.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Cultivated Wheat Pollenis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Cultivated Wheat Pollen Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to cultivated wheat pollen — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of cultivated wheat pollen allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of cultivated wheat pollen immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of cultivated wheat pollen extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for cultivated wheat pollen allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing cultivated wheat pollen extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription cultivated wheat pollen immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat cultivated wheat pollen allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Cultivated Wheat Pollen?
The biology, taxonomy, and clinical fingerprint of Cultivated Wheat Pollen — the foundation of how SCIT targets it.
Cultivated wheat (Triticum aestivum) at anthesis — wheat is largely self-pollinated (cleistogamous), releasing pollen inside closed florets before the flower opens. Airborne pollen per acre is far lower than wind-pollinated cereals like rye, but total US output is significant given 45 million acres of cultivation. Pollen allergy is completely distinct from wheat food allergy and celiac disease.
- Scientific name
- Triticum aestivum
- Family
- Poaceae (Pooideae)Grass family — cool-season Pooideae cereals
- Type
- Annual cool-season cereal crop pollen — largely self-pollinated (cleistogamous); occupational aeroallergen
- Native to
- Fertile Crescent (Southwest Asia); the world's most cultivated cereal. US acreage (~45 million acres) concentrated in Kansas, North Dakota, Montana, Oklahoma, Texas, Washington, and Idaho
- Allergen proteins
- Tri a 12 — profilin (pan-allergen)Tri a 14 — non-specific lipid transfer protein (nsLTP)Tri a 18 — agglutininTri a 19 — omega-5 gliadin: THIS IS A FOOD ALLERGEN causing wheat-dependent exercise-induced anaphylaxis — NOT a pollen allergen (Palosuo et al., 1999, JACI)Tri a 1 and Tri a 5 — pollen-specific Group 1 and Group 5 homologs inferred from Pooideae cereal conservation; cross-reactive with Timothy Phl p 1/5 (Andersson & Lidholm, 2003)
- Particle size
- 35–50 μm
- Avoidance difficulty
- Moderate
How Cultivated Wheat Pollen Allergy Presents
Symptoms by body system — useful for distinguishing Cultivated Wheat Pollen sensitivity from overlapping allergies and infections.
Respiratory
- Seasonal sneezing and rhinorrhea during May–June wheat anthesis in the Plains and Pacific Northwest
- Nasal congestion in farmers operating combines and harvesters during wheat maturation
- Asthma exacerbations in grain elevator workers and millers exposed to wheat pollen dust during peak season
- Occupational rhinitis in agricultural workers within drift distance of the 45-million-acre US wheat belt
- Note: baker's asthma from wheat flour inhalation is a SEPARATE occupational lung condition — not pollen allergy
Ocular
- Eye itching and tearing during May–June wheat pollen season in grain-growing states
- Conjunctival redness in farmworkers during active wheat field operations at anthesis
- Increased ocular sensitivity on warm, dry, windy Plains mornings during flowering
Dermal
- Contact dermatitis in grain handlers with prolonged skin contact with wheat stalks during harvest
- Mild rash in farm workers with occupational wheat exposure
Systemic
- Fatigue from simultaneous wheat, rye, and Pooideae grass pollen exposure during May–June
- Reduced farm work capacity during wheat flowering operations
- Sleep disruption from nasal congestion during active harvest and planting periods
Wheat is the entry on the allergy panel that generates the most patient confusion — and the most important clinical clarification I give. When someone sees 'wheat allergy' and thinks their bread is the problem, I explain that there are five distinct conditions involving wheat, and pollen allergy is one of them. The SCIT we're discussing treats only the wind-borne pollen exposure in grain workers — it has absolutely no effect on celiac disease or wheat food allergy.
When & Where Cultivated Wheat Pollen Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: May–June across the Plains; June–July in the Pacific Northwest (Spokane and the Palouse); overlaps with Timothy and Kentucky bluegrass pollen seasons· April–July; later in PNW and northern growing zones; brief season consistent with other cereal Pooideae crops
US Exposure Map
7 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- High
- MT:
- High
- ND:
- High
- MN:
- Moderate
- WI:
- Low
- MI:
- Moderate
- NY:
- Low
- MA:
- Low
- OR:
- Moderate
- ID:
- High
- WY:
- Moderate
- SD:
- Moderate
- IA:
- Low
- IL:
- Low
- IN:
- Low
- OH:
- Moderate
- PA:
- Moderate
- NJ:
- Low
- CT:
- Low
- RI:
- Low
- CA:
- Low
- NV:
- Low
- UT:
- Low
- CO:
- Moderate
- NE:
- Moderate
- MO:
- Low
- KY:
- Low
- WV:
- Low
- VA:
- Low
- MD:
- Low
- DE:
- Low
- AZ:
- Low
- NM:
- Low
- KS:
- High
- AR:
- Low
- TN:
- Low
- NC:
- Low
- SC:
- Low
- OK:
- High
- LA:
- Low
- MS:
- Low
- AL:
- Low
- GA:
- Low
- TX:
- High
- FL:
- Low
- AK:
- Low
- HI:
- Low
What Cultivated Wheat Pollen Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Cultivated wheat pollen (Pooideae) shares Tri a 1 and Tri a 5 cross-reactivity with the full Pooideae grass cluster through Group 1 and Group 5 allergen homology — making a Timothy-anchored Pooideae SCIT vial the standard empirical coverage approach for wheat pollen sensitization.
Pooideae — Tri a 1/5 cross-reactive with Phl p 1/5; Timothy SCIT provides strong empirical wheat pollen coverage (Andersson & Lidholm, 2003)
Pooideae cereal — Sec c 1/5 cross-reactivity with Tri a 1/5; co-cultivated in Plains grain-farming regions
Pooideae — ~90% Group 1 cross-reactivity; overlapping May–July season across wheat-growing states
Pooideae — Lol p 1/5 high cross-reactivity with Tri a 1/5 (note: Lolium ≠ Secale despite shared 'rye' common name)
Is SCIT Right for Your Cultivated Wheat Pollen Allergy?
Answer five questions to assess your candidacy for Pooideae grass SCIT providing empirical wheat pollen coverage.
How severe are your May–June grain field pollen symptoms in wheat-growing areas?
The Cultivated Wheat Pollen SCIT Protocol
Cultivated wheat pollen SCIT is conducted empirically via a Pooideae grass mix vial anchored by FDA-standardized Timothy (100,000 BAU/mL), which provides strong Tri a 1/5 cross-coverage through Group 1 and Group 5 allergen homology. A standalone non-standardized wheat pollen extract (ImmunoCAP g15) is available but is rarely used as monotherapy; the Pooideae mix approach is preferred.
The Pooideae mix vial escalates from dilute to maintenance under 30-minute post-injection observation. Because wheat anthesis peaks in May–June, beginning build-up in fall or winter allows reaching maintenance before the following grain season. Curex uses a conservative once-weekly build-up and does not offer rush or cluster schedules; the gradual escalation is by design.
Ongoing maintenance sustains Pooideae tolerance through the brief but intense wheat pollen season. Agricultural patients often schedule maintenance visits during fall and winter to accommodate planting and harvest schedules. SCIT does NOT modify wheat food allergy or celiac disease — those conditions require dietary management regardless of immunotherapy status.
Patients completing a full Pooideae SCIT course typically experience sustained symptom reduction for years after stopping, including during annual wheat harvesting operations. Agricultural patients with ongoing high occupational exposure may continue maintenance indefinitely in consultation with their allergist.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Cultivated Wheat Pollen SCIT
No published double-blind placebo-controlled SCIT trial has used cultivated wheat (Triticum aestivum) pollen extract as its primary intervention — an honest data gap explicitly acknowledged here. Efficacy is extrapolated from the Pooideae grass SCIT evidence base via Tri a 1/5 cross-reactivity with Phl p 1/5.
- Grass SCIT symptom score reduction (Pooideae meta-analysis)40%Calderón M et al., 2007, Cochrane Database Syst Rev — broad grass SCIT systematic review
- Timothy SCIT efficacy (Pooideae class reference)82%Frew AJ et al., 2006, JACI meta-analysis — Timothy and Pooideae grass SCIT
- Tri a 1/5 cross-reactivity with Phl p 1/5 (Pooideae conservation)88%Andersson & Lidholm, 2003, Int Arch Allergy Immunol — Pooideae cereal allergen conservation
No wheat-pollen-specific SCIT RCT has been published as of 2024. The clinical basis for empirical Pooideae SCIT coverage rests on the well-established Tri a 1/5 / Phl p 1/5 cross-reactivity and the Frew 2006 JACI meta-analysis (82% Pooideae SCIT efficacy). The most important clinical context is the five-way disambiguation: SCIT specifically addresses the aeroallergen pollen condition in grain workers — it has no effect on wheat food allergy, celiac disease, WDEIA, or baker's asthma, all of which require entirely different management.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Cultivated Wheat Pollen SCIT Side Effects
Pooideae grass mix SCIT for wheat pollen sensitization carries the standard inhalant SCIT local and systemic reaction profile, managed through the mandatory 30-minute post-injection observation period.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site swelling Wheal and flare at injection arm; resolves within hours | Rate 30–50% | Mild |
Injection-site itching Pruritus at injection site; cold compress provides relief | Rate 25–40% | Mild |
Large local reaction (>25 mm) May require dose adjustment; inform allergist before next visit | Rate 5–10% | Moderate |
Delayed induration Firm lump persisting 24–48 hours; resolves without treatment | Rate 2–5% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Nasal/conjunctival flare Brief worsening of baseline pollen allergy symptoms post-injection | Rate 0.5–1% | Mild |
Generalized urticaria Managed with antihistamines; dose reduction at next visit | Rate 0.1–0.3% | Moderate |
Mild bronchospasm More likely in patients with poorly controlled asthma; pre-treatment spirometry recommended for agricultural workers with occupational lung disease | Rate 0.1–0.2% | Moderate |
Systemic anaphylaxis Managed with epinephrine; before the first wheat-pollen dose Curex confirms a prescribed auto-injector on hand and supervises that dose and every dose change live in the Virtual Shot Room | Rate <0.01% | Severe |
No deaths from inhalant SCIT have been reported in the US in the past decade under proper protocols. Pooideae grass mix SCIT carries the well-established safety record of Timothy-anchored standardized grass immunotherapy. Curex preserves that record at home with a USP <797> serum, Virtual Shot Room–supervised the first injection from each new vial or concentration, a prescribed epinephrine auto-injector confirmed on hand, and allergist-overseen escalation.
SCIT vs Alternatives for Cultivated Wheat Pollen
Plains and Pacific Northwest grain workers with wheat pollen sensitization have four main management options: Pooideae grass SCIT, at-home SLIT drops, occupational personal protective equipment strategies, or seasonal symptom medications.
| Criterion | At-Home SCIT (Curex)Best | SLIT drops/tablets | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Disease-modifying via Pooideae mix; 40–82% class evidence (Calderón 2007, Frew 2006) | Moderate — Grastek (Timothy) covers Pooideae class; custom wheat-specific drops available | Moderate — N95 mask + cab filtration during harvest operations | Symptom suppression during brief season |
| 5-yr cost | $3,500–$10,000 | $1,500–$4,000 | Low direct cost | $200–$1,500 |
| Duration | 3–5 years | 3–5 years | Ongoing seasonal PPE use | Annual 6–8 week course |
| Convenience | At-home self-injection; weekly build-up → maintenance on allergist-set schedule | Daily drops at home | Requires PPE discipline during field work | Easy — oral/nasal |
| Safety | <0.01% anaphylaxis; Virtual Shot Room–supervised dosing + prescribed epi | Very low systemic risk | Excellent | Caution: drowsiness risk for machinery operators |
| Lasting effect | 7–12+ years post-course | Moderate lasting effect | No disease modification | None — symptoms return each planting season |
At-Home SCIT (Curex)Best
SLIT drops/tablets
Avoidance
Medications
For grain farmers with documented Pooideae sensitization and wheat field exposure, Pooideae SCIT provides the most durable disease-modifying outcome across the cereal grass season. Curex delivers that SCIT as an at-home allergy shot with pricing confirmed in a current program quote — a Timothy/Pooideae cereal serum (covering the Tri a cross-reactivity spectrum) compounded under USP <797>, with the first injection from each new vial or concentration supervised live in the Virtual Shot Room, a prescribed epinephrine auto-injector confirmed on hand, and allergist-overseen weekly escalation — so eligible grain workers reach maintenance without clinic scheduling during planting and harvest.
What Cultivated Wheat Pollen SCIT Actually Costs
Pooideae grass mix SCIT is covered by most major US insurers under standard allergy benefits. Curex's at-home IgE panel separates Triticum pollen sensitization from Tri a 19 food allergy markers, helping grain workers document the aeroallergen basis for their SCIT prior authorization. Agricultural workers should confirm whether employer insurance plans include occupational allergy management coverage pathways.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your cultivated wheat pollen allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Cultivated Wheat Pollen SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
The five distinct wheat-related conditions are: (1) Wheat pollen allergy — IgE-mediated response to wind-borne pollen proteins from Triticum aestivum fields; treated with SCIT or SLIT targeting aeroallergens. (2) Wheat food allergy — IgE-mediated response to wheat seed storage proteins (glutenins, gliadins); can cause urticaria, vomiting, or anaphylaxis after eating wheat-containing foods; managed by avoidance and epinephrine access. (3) Celiac disease — autoimmune T-cell response to gliadin causing intestinal villous atrophy; NOT IgE-mediated; treated with strict lifelong gluten-free diet. (4) Baker's asthma — occupational asthma from inhalation of wheat flour proteins (high-MW glutenins), not pollen; affects commercial bakers; managed through occupational exposure reduction and bronchodilators. (5) Non-celiac gluten sensitivity — controversial entity with gastrointestinal symptoms attributed to gluten without celiac autoimmunity or IgE; management is dietary. SCIT treats condition 1 only — it has no effect on conditions 2 through 5.
No. Wheat pollen allergy is an airborne sensitization to pollen proteins from Triticum aestivum plants — immunologically distinct from the seed storage proteins (gliadins, glutenins) that trigger wheat food allergy and celiac disease. Pollen proteins and grain proteins do not cross-react in a clinically meaningful way for most patients. Eating oatmeal, bread, pasta, or other wheat-containing foods will not trigger wheat pollen allergy reactions, and conversely, wheat pollen exposure during field season will not cause gastrointestinal symptoms in patients with celiac disease. The gluten-free diet is the appropriate management for celiac disease and is not indicated for wheat pollen aeroallergen sensitization. A board-certified allergist can help distinguish between these conditions through specific IgE testing: Tri a 19 (omega-5 gliadin) is the food/WDEIA marker, while Tri a 1/5 proxy testing via Phl p 1/5 identifies pollen sensitization.
Triticum aestivum is largely self-pollinated via a process called cleistogamy — the anthers (pollen-producing organs) release pollen inside closed or nearly closed florets before the flower fully opens, allowing fertilization without requiring airborne pollen transfer. This dramatically reduces per-acre airborne pollen output compared to wind-pollinated cereals like rye (Secale cereale), which is self-incompatible and must generate massive pollen clouds to enable cross-pollination between plants. Fritz & Lukaszewski (1989, Crop Science) documented up to 4 million pollen grains per rye spike, while wheat pollen output per floret is orders of magnitude lower. Despite wheat's dominant US acreage (~45 million acres versus ~2 million for rye), the total atmospheric wheat pollen burden in grain-growing states is lower per acre. However, the aggregate scale of wheat cultivation means total US wheat pollen output is still climatologically significant during May–June anthesis.
Wheat-dependent exercise-induced anaphylaxis (WDEIA) is a severe IgE-mediated food allergy triggered specifically by eating wheat and then engaging in physical exercise within 2–4 hours. The causative allergen is Tri a 19 (omega-5 gliadin), a wheat seed storage protein detectable by specific IgE testing. WDEIA is diagnosed by documenting Tri a 19 IgE sensitization plus a characteristic clinical history and, in some cases, provocation testing under medical supervision. It is entirely separate from wheat pollen aeroallergen allergy — WDEIA is caused by ingested food proteins, not inhaled pollen proteins, and is not treated by SCIT. Wheat pollen SCIT addresses only the airborne Tri a 1/5-mediated aeroallergen condition in grain workers and does not modify Tri a 19 food sensitization in any way. Palosuo et al. (1999, JACI) and Morita et al. (2003, JACI) are the primary clinical references for WDEIA characterization.
No. Baker's asthma is an occupational lung disease caused by inhalation of wheat flour proteins — high-molecular-weight glutenins, albumins, and globulins in airborne flour dust — by bakers, millers, and grain handlers. It affects approximately 9% of commercial bakers (Houba et al., 1998, Am J Ind Med) and is an IgE-mediated asthma distinct from pollen allergy. Wheat flour proteins are different molecules from wheat pollen proteins; both are from Triticum aestivum but from different parts of the plant and released in entirely different occupational contexts. Wheat pollen allergy is a seasonal aeroallergen condition affecting farmers and rural residents during the May–June anthesis period; baker's asthma is a year-round occupational exposure condition in flour-processing environments. Pollen SCIT does not treat baker's asthma, and occupational flour exposure management (ventilation, PPE, job rotation) does not address pollen sensitization.
Wheat pollen aeroallergen sensitization is most prevalent among grain farmers, grain elevator workers, combine operators, and agricultural workers in wheat-growing states (Kansas, North Dakota, Montana, Oklahoma, Texas, Washington, Idaho) who have prolonged direct field exposure during May–June anthesis. Rural residents within ambient drift distance of large wheat-growing operations also have elevated exposure risk. Doekes et al. (1996, Allergy) identified wheat as the single most common occupational aeroallergen for Plains grain handlers. Atopic individuals — those with existing hay fever, asthma, or eczema — have higher risk of developing new sensitizations from occupational pollen exposure. Early intervention with appropriate respiratory protection during peak anthesis, combined with periodic IgE monitoring in occupationally exposed workers, is recommended by occupational medicine guidelines for agricultural communities.
Grastek (Timothy SLIT tablet) is FDA-approved for Pooideae grass allergy and provides strong empirical cross-coverage for wheat pollen via Tri a 1/5 / Phl p 1/5 cross-reactivity. No FDA-approved SLIT product specifically targets Triticum aestivum pollen. Custom sublingual drops can include Timothy and Pooideae cereal components at therapeutic concentrations for at-home use. Head-to-head comparison between Pooideae SLIT and SCIT for wheat pollen sensitization specifically has not been published. The broader grass SLIT versus SCIT literature suggests comparable efficacy for Pooideae class allergens, with SCIT having a modest advantage in systematic reviews. For grain farmers who cannot sustain weekly clinic visits during the spring planting season, at-home SLIT drops represent a clinically meaningful alternative. Self-administered immunotherapy has a strong safety record as well: a large safety study of self-administered allergen immunotherapy (Schaffer et al., 2015) found that across 23,614 patients giving 2,021,600 injections, the systemic reaction rate was just 0.16% per patient with no fatalities — lower than the 3%–14% typically seen with office-based shots. A board-certified allergist should guide the choice based on sensitization level, symptom severity, and the patient's agricultural schedule.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.